{"nctId":"NCT00174252","briefTitle":"Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age","startDateStruct":{"date":"2005-02"},"conditions":["Fetal Growth Retardation"],"count":57,"armGroups":[{"label":"Genotonorm (Somatropin)","type":"EXPERIMENTAL","interventionNames":["Drug: Genotonorm (Somatropin)"]}],"interventions":[{"name":"Genotonorm (Somatropin)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Chronological age between 4 and 9 years for a boy and 4 and 7 years for a girl.\n* Measured Height \\< -2.5 Standard Deviation\n\nExclusion Criteria:\n\n* Pubertal signs ie: testis volume \\> or = 4 ml in boys and breast stage \\> or = B2 (Tanner)\n* Serious chronic disease (diabetes, renal insufficiency, heart failure, hepatic insufficiency, neoplasia)","healthyVolunteers":false,"sex":"ALL","minimumAge":"4 Years","maximumAge":"9 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"OTHER_PRE_SPECIFIED","title":"Change in Height From Baseline","description":"The standing height measurements were performed at the same time of the day by using a wallmounted device (e.g. Harpenden Stadiometer) at each study visit. The pre-specified clinical outcomes were analyzed at 12 and 24 months.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.0","spread":"1.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.4","spread":"2.2"}]}]}]},{"type":"PRIMARY","title":"Percentage of Children With Insulin Growth Factor-1 (IGF-1) > 2 Standard Deviation (SD) at 9 and 12 Months","description":"Percentage of children with serum IGF-1 \\> 2 SD (compared to a child of the same gender and age and without growth hormone (GH) deficiency) 9 months and 12 months after initiation of GH treatment. 9 months and 12 months are combined.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"86.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Height SD Chronological Age (CA) From Baseline at 12 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"The height in SD was calculated using Sempe reference means and standard deviations for height. Change in height SD was calculated as height in SD at \"12 months\" minus height in SD at \"Baseline\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"0.26"}]}]}]},{"type":"SECONDARY","title":"Change in Height SD CA From Baseline at 24 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"The height in SD was calculated using Sempe reference means and SDs for height. Change in height SD was calculated as height in SD at \"24 months\" minus height in SD at \"Baseline\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.24","spread":"0.48"}]}]}]},{"type":"SECONDARY","title":"Change in Height SD CA From Baseline at 12 and 24 Months in Children With IGF-1 > 2 SD at 9 and 12 Months","description":"The height in SD was calculated using Sempe reference means and SDs for height. Change in height SD was calculated as height in SD at \"12 or 24 months\" minus height in SD at \"Baseline\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.13","spread":"0.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.53","spread":"0.20"}]}]}]},{"type":"SECONDARY","title":"Change in Height SD Bone Age (BA) From Baseline at 12 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"The height in SD was calculated using Sempe reference means and SDs for height. Change in height SD was calculated as height in SD at \"12 months\" minus height in SD at \"Baseline\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.44","spread":"1.34"}]}]}]},{"type":"SECONDARY","title":"Change in Height SD BA From Baseline at 24 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"The height in SD was calculated using Sempe reference means and SDs for height. Change in height SD was calculated as height in SD at \"24 months\" minus height in SD at \"Baseline\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"1.86"}]}]}]},{"type":"SECONDARY","title":"Change in Height SD BA From Baseline at 12 and 24 Months in Children With IGF-1 > 2 SD at 9 and 12 Months","description":"The height in SD was calculated using Sempe reference means and SDs for height. Change in height SD was calculated as height in SD at \"12 or 24 months\" minus height in SD at \"Baseline\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":"1.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":"1.30"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Growth Rate at 12 and 24 Months","description":"Growth Rate was calculated at 12 months as:\n\n(Height at 12 months minus Height at Day 0) divided by {(Date of 12 months minus Date of Day 0) divided by 365.25}\n\nGrowth Rate was calculated at 24 months as:\n\n(Height at 24 months minus Height at 12 months) divided by {(Date of 24 months minus Date of 12 months) divided by 365.25}","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.06","spread":"1.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.23","spread":"1.38"}]}]}]},{"type":"SECONDARY","title":"Summary of Growth Rate SD (CA) at 12 and 24 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"Growth rate SD CA at 12 months was calculated as:(Growth rate at 12 months minus reference mean for CA at 12 months) divided by reference SD for CA at 12 months\n\nGrowth rate SD CA at 24 months was calculated as:(Growth rate at 24 months minus reference mean for CA at 24 months) divided by reference SD for CA at 24 months","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.77","spread":"1.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.74","spread":"1.51"}]}]}]},{"type":"SECONDARY","title":"Summary of Growth Rate SD (CA) at 12 and 24 Months in Children With IGF-1 > 2 SD at 9 and 12 Months","description":"Growth rate SD CA at 12 months was calculated as: (Growth rate at 12 months minus reference mean for CA at 12 months) divided by reference SD for CA at 12 months\n\nGrowth rate SD CA at 24 months was calculated as: (Growth rate at 24 months minus reference mean for CA at 24 months) divided by reference SD for CA at 24 months","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.24","spread":"1.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.15","spread":"2.21"}]}]}]},{"type":"SECONDARY","title":"Summary of Growth Rate SD (BA) at 12 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"Growth rate SD BA at 12 months was calculated as: (Growth rate at 12 months minus reference mean for BA at 12 months) divided by reference SD for BA at 12 months","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.38","spread":"1.88"}]}]}]},{"type":"SECONDARY","title":"Summary of Growth Rate SD (BA) at 24 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"Growth rate SD BA at 24 months was calculated as: (Growth rate at 24 months minus reference mean for BA at 24 months) divided by reference SD for BA at 24 months","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.26","spread":"1.62"}]}]}]},{"type":"SECONDARY","title":"Summary of Growth Rate SD (BA) at 12 and 24 Months in Children With IGF-1 > 2 SD at 9 and 12 Months","description":"Growth rate SD BA at 12 months was calculated as: (Growth rate at 12 months minus reference mean for BA at 12 months) divided by reference SD for CA at 12 months\n\nGrowth rate SD BA at 24 months was calculated as: (Growth rate at 24 months minus reference mean for BA at 24 months) divided by reference SD for CA at 24 months","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.02","spread":"2.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.71","spread":"2.26"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Summary of Body Mass Index (BMI) at 12 and 24 Months","description":"BMI was calculated at 12 months and 24 months as: (Weight at 12 or 24 months divided by Height at 12 or 24 months) squared","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.7","spread":"1.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.9","spread":"1.4"}]}]}]},{"type":"SECONDARY","title":"Analysis of Covariance (ANCOVA) for Height SD CA at 12 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months and IGF-1 > 2 SD at 9 and 12 Months","description":"Change in Height SD (CA) was calculated as:\n\nHeight SD (CA) at 12 months minus Height SD (CA) at Baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.94","spread":"0.04"},{"groupId":"OG001","value":"-1.59","spread":"0.10"}]}]}]},{"type":"SECONDARY","title":"ANCOVA for Height SD CA at 24 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months and IGF-1 > 2 SD at 9 and 12 Months","description":"Height SD (CA) at 24 months.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.53","spread":"0.06"},{"groupId":"OG001","value":"-1.18","spread":"0.14"}]}]}]},{"type":"SECONDARY","title":"ANCOVA for Height SD BA at 12 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months and IGF-1 > 2 SD at 9 and 12 Months","description":"Change in Height SD (BA) was calculated as:\n\nHeight SD (BA) at 12 months minus Height SD (BA) at Baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.56","spread":"0.22"},{"groupId":"OG001","value":"0.76","spread":"0.48"}]}]}]},{"type":"SECONDARY","title":"ANCOVA for Height SD BA at 24 Months in Children With IGF-1 <= 2 SD at 9 or 12 Months and IGF-1 > 2 SD at 9 and 12 Months","description":"Height SD (BA) at 24 months","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"0.25"},{"groupId":"OG001","value":"0.64","spread":"0.53"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in BA From Baseline at 12 and 24 Months","description":"Change in BA was calculated as: (12 or 24 months minus Screening)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"0.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"1.1"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"BA/CA at 12 and 24 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"The BA/CA ratio was calculated at Screening, 12 and 24 months. The CA was the age on the date that the corresponding BA X-ray was performed.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.74","spread":"0.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"0.16"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"BA/CA at 12 and 24 Months in Children With IGF-1 > 2 SD at 9 and 12 Months","description":"The BA/CA ratio was calculated at Screening, 12 and 24 months. The CA was the age on the date that the corresponding BA X-ray was performed.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.80","spread":"0.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.83","spread":"0.09"}]}]}]},{"type":"SECONDARY","title":"Summary of IGF-1 SD at 6, 9, 12, 15, 18, 21, and 24 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":"IGF-1 SD was calculated at each study time point using gender specific IGF-1 reference mean and SD for the CA of the child on the date of the corresponding IGF-1 blood sample: IGF-1 SD = (IGF-1 minus reference mean) divided by reference SD","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.65","spread":"1.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.93","spread":"1.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.04","spread":"0.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.88","spread":"1.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.88","spread":"1.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"0.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.85","spread":"1.17"}]}]}]},{"type":"SECONDARY","title":"Summary of IGF-1 SD at 6, 9, 12, 15, 18, 21, and 24 Months in Children With IGF-1 > 2 SD at 9 and 12 Months","description":"IGF-1 SD was calculated at each study time point using these gender specific IGF-1 reference means and SDs for the CA of the child on the date of the corresponding IGF-1 blood sample: IGF-1 SD = (IGF-1 - reference mean) / reference SD","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.32","spread":"0.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.35","spread":"0.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.50","spread":"0.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":"1.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.12","spread":"1.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.82","spread":"1.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.81","spread":"1.03"}]}]}]},{"type":"SECONDARY","title":"IGF-1/Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3) Ratio at 12 and 24 Months in Children With IGF-1 < = 2 SD at 9 or 12 Months","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.17","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.19","spread":"0.07"}]}]}]},{"type":"SECONDARY","title":"IGF-1/IGFBP-3 Ratio at 12 and 24 Months in Children With IGF-1 > 2 SD at 9 and 12 Months","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.23","spread":"0.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.21","spread":"0.06"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":57},"commonTop":["Varicella","Bronchitis","Headache","Constipation","Nasopharyngitis"]}}}